Martin Štefanič
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 10
- Hematopoietic Stem Cell Transplantation 5
- Acute Myeloid Leukemia Research 4
- Co-authors
- Donald Bunjes (9 shared papers)H. Heimpel (6 shared papers)Peter Stopfer (7 shared papers)Bernd Hertenstein (6 shared papers)R. Kaiser (6 shared papers)Markus Wiesneth (6 shared papers)C. Buck (5 shared papers)W. Digel (5 shared papers)
In The Last Decade
Martin Štefanič
38 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 98
- Hematology 319
- Genetics 164
- Oncology 349
- Immunology 252
- Pulmonary and Respiratory Medicine 351
Countries citing papers authored by Martin Štefanič
This map shows the geographic impact of Martin Štefanič's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Štefanič with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Štefanič more than expected).
Fields of papers citing papers by Martin Štefanič
This network shows the impact of papers produced by Martin Štefanič. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Štefanič. The network helps show where Martin Štefanič may publish in the future.
Co-authors
The 25 scholars most cited alongside Martin Štefanič, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 144 | |
| 2 | 1989 | 134 | |
| 3 | 2001 | 126 | |
| 4 | 2011 | 124 | |
| 5 | 1994 | 116 | |
| 6 | 1994 | 73 | |
| 7 | 1993 | 68 | |
| 8 | 2017 | 62 | |
| 9 | 2000 | 47 | |
| 10 | 2012 | 39 | |
| 11 | 2005 | 28 | |
| 12 | 1990 | 28 | |
| 13 | In vivo/ex vivo T cell depletion reduces the morbidity of allogeneic bone marrow transplantation in patients with acute leukaemias in first remission without increasing the risk of treatment failure: comparison with cyclosporin/methotrexate. | 1995 | 28 |
| 14 | 2009 | 27 | |
| 15 | An open-label dose-escalation study of BIBF 1120 in patients with relapsed or refractory multiple myeloma. | 2009 | 27 |
| 16 | 2012 | 23 | |
| 17 | 2006 | 23 | |
| 18 | Tumor necrosis factor-alpha, but not lymphotoxin, stimulates growth of tumor cells in hairy cell leukemia. | 1990 | 21 |
| 19 | 2017 | 21 | |
| 20 | 2005 | 19 |
About Martin Štefanič
Martin Štefanič is a scholar working on Hematology, Molecular Biology, Genetics, Pulmonary and Respiratory Medicine and Immunology, having authored 39 papers that have together received 1.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (6 papers), Bone Tissue Engineering Materials (5 papers), Hematopoietic Stem Cell Transplantation (5 papers), Dental materials and restorations (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Acute Myeloid Leukemia Research (4 papers) and Phagocytosis and Immune Regulation (4 papers). The work is most often cited by research in Hematology (319 citations), Genetics (164 citations), Oncology (349 citations), Immunology (252 citations) and Pulmonary and Respiratory Medicine (351 citations). Martin Štefanič has collaborated with scholars based in Germany, Slovenia and Austria. Frequent co-authors include Donald Bunjes, H. Heimpel, Peter Stopfer, Bernd Hertenstein, R. Kaiser, Markus Wiesneth, C. Buck, W. Digel, Franz Porzsolt and Tomaž Kosmac̆. Their work appears in journals such as Blood, Journal of Clinical Oncology, Journal of the European Ceramic Society, Clinical Cancer Research and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.